Joel Greenblatt · Magic Formula: alta rentabilidad del capital a un EV/EBIT bajo
Is Alnylam Pharmaceuticals, Inc. (ALNY) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
59/100
Mixto
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a ALNY
EBIT/EV yield ≥ 10%
clave1.3%
ROIC ≥ 25%
clave19.7%
EV/EBIT ≤ 12
77.8x
Gross margin ≥ 30%
80.9%
Cómo se valora ALNY en otras estrategias
Datos financieros en vivo
Cap. mercado
$29.4B
PER (TTM)
68.1x
ROIC (TTM)
19.66%
Margen bruto
80.89%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is ALNY's Joel Greenblatt fit score?
ALNY scores 59/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own ALNY?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ALNY.
How often is this score updated?
ALNY's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende ALNY personalmente.
